Artificial Intelligence: Evolution, challenges and opportunities for supportive care in cancer.
November 14, 12 to 1 p.m. ET
From the early work of British mathematician Alan Turing in the 1930s, Artificial Intelligence has steadily evolved until, most recently, when there has been a veritable explosion to apply AI solutions in multiple sectors, including healthcare. This evolution has taken several paths, and the journey has not been without challenges. This webinar will take participants through the AI journey, and the discussion will focus on these challenges and opportunities for AI in supportive oncology.
Participants will gain an understanding of:
- The evolution of AI
- Application of AI “types” in healthcare generally and oncology specifically
- AI Challenges: application and deployment
- Opportunities for AI in Supportive Oncology
Featured Speaker:
-
Fred Ashbury, PhD, MACE, Chief Scientific Officer, VieCure, Denver CO US
- 30+ Years of Cancer Leadership Experience
- Former CSO with OpTx Corp
- Former Senior Executive with Cancer Care Ontario and Alberta Cancer Board
Fred is a co-founder and Chief Scientific Officer at VieCure. He is responsible for developing, maintaining, and codifying VieCure’ s oncology clinical content knowledge base, and the design and implementation of the diagnostic, treatment, supportive care and post-treatment rehabilitation and survivorship rules that underpin VieCure’s platform. With colleagues, Fred holds the only patented Artificial Intelligence decision-support platform in healthcare (US Patent No. 17,798,689 B2): “Capability to Create Personalized Healthcare Treatment Plans for Individuals with Medical Conditions”
He received his bachelor’s degree (honors) from the University of Toronto, his master’s degree from Queen’s University, and his doctorate from York University. Fred’s career focus has been medical oncology and behavioral sciences.
He is a former senior executive with the National Cancer Institute of Canada, Cancer Care Ontario, the Alberta Cancer Board, OpTx Corporation, and BridgeSite Clinical Research.
He co-founded Intelligent Improvement Consultants, a healthcare management consulting firm. Fred founded two other successful healthcare management consultancies with clients in the US, Canada, UK, Germany, and Australia earning several million dollars in revenue.
Fred has mentored oncology practices and networks worldwide to define key performance indicators and quality metrics based on current evidence and practice, used to establish practice accountability, reporting and quality improvement.
He is a member of the American Society of Clinical Oncology; board member for the Multi-National Association of Supportive Care in Cancer (MASCC); Chair of the Guidelines Committee, MASCC; and member of the University of Swinburne Industry Research Advisory Committee.
His university appointments include the Department of Internal Medicine, Medical Oncology, The Ohio State University, USA and the Department of Oncology, University of Calgary. He has published more than 100 peer-reviewed articles and major reports in oncology health services delivery, quality in cancer care, and supportive care. Fred is the Editor-in-Chief for the top-ranked journal, Supportive Care in Cancer, and sits on the editorial boards of the British Medical Journal (Open) and SN: Comprehensive Clinical Sciences.
Registration fees:
- FREE to CAPO Members.
- $15 to non-members
Webinar access details will be provided in your registration confirmation email.
If you are not a current member of CAPO, find out more about membership by going to https://capo.ca/apply
